XML 130 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2019
Amounts Charged to Income for Employees Incentive Compensation Plans
The amounts charged to expense for Progressive and ARX incentive compensation plans for the years ended December 31, were:
 
2019
 
2018
 
2017
(millions)
Pretax

After Tax

 
Pretax

After Tax

 
Pretax

After Tax

Non-equity incentive plans  cash
$
598.4

$
472.7

 
$
539.5

$
426.2

 
$
461.3

$
299.8

Equity incentive plans:
 
 
 
 
 
 
 
 
     Equity awards
90.1

71.2

 
76.2

60.2

 
92.9

60.4

     Liability awards
0.1

0.1

 
1.0

0.8

 
2.5

1.6


Assets Held in Deferral Plan Irrevocable Grantor Trust Account The Deferral Plan Irrevocable Grantor Trust account held the following assets at December 31:
(millions)
2019

2018

Progressive common shares
$
121.6

$
114.7

Other investment funds2
151.2

124.0

Total
$
272.8

$
238.7

1 Included 3.2 million and 3.6 million common shares as of December 31, 2019 and 2018, respectively, to be distributed in common shares, and are reported at grant date fair value.
2 Amount is included in other assets on the consolidated balance sheets.
Employee  
Summary of Restricted Stock Activity
A summary of all employee restricted equity award activity during the years ended December 31, follows:
 
2019
 
2018
 
2017
Restricted Equity Awards
Number of Shares1

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares1 

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares1 

Weighted
Average
Grant
Date Fair
Value

Beginning of year
4,856,356

$
38.56

 
5,858,848

$
30.47

 
6,951,373

$
26.18

Add (deduct):
 
 
 
 
 
 
 
 
Granted
1,835,145

49.61

 
1,876,109

45.55

 
2,383,475

32.01

Vested
(2,691,337
)
31.85

 
(2,811,070
)
26.41

 
(3,220,671
)
22.53

Forfeited
(121,087
)
43.98

 
(67,531
)
36.10

 
(255,329
)
28.03

End of year3,4
3,879,077

$
48.28

 
4,856,356

$
38.56

 
5,858,848

$
30.47

1 Includes restricted stock units. All performance-based awards are included at their target amounts.
2 We reinvest dividend equivalents on restricted stock units. For 2019, 2018, and 2017, the number of units “granted” shown in the table above includes 210,159, 144,668, and 157,396 of dividend equivalent units, respectively, at a weighted average grant date fair value of $0, since the dividends were factored into the grant date fair value of the original grant.
3 At December 31, 2019, the number of shares included 726,712 performance-based units at their target amounts. We expect 1,740,712 units to vest based upon our current estimates of the likelihood of achieving the pre-determined performance goals applicable to each award.
4 At December 31, 2019, the total unrecognized compensation cost related to unvested equity awards was $95.9 million, which includes performance-based awards at their currently estimated vesting value. This compensation expense will be recognized into the consolidated statements of comprehensive income over the weighted average vesting period of 2.3 years.
Director  
Summary of Restricted Stock Activity
A summary of all directors’ restricted stock activity during the years ended December 31, follows:
 
2019
 
2018
 
2017
Restricted Stock
Number of
Shares

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares

Weighted
Average
Grant
Date Fair
Value

 
Number of
Shares

Weighted
Average
Grant
Date Fair
Value

Beginning of year
41,706

$
62.23

 
53,284

$
40.54

 
55,839

$
33.24

Add (deduct):
 
 
 
 
 
 
 
 
Granted
38,451

73.43

 
41,706

62.23

 
53,284

40.54

Vested
(41,706
)
62.23

 
(53,284
)
40.54

 
(55,839
)
33.24

End of year1
38,451

$
73.43

 
41,706

$
62.23

 
53,284

$
40.54


1 At December 31, 2019, 2018, and 2017, the remaining unrecognized compensation cost related to restricted stock awards was $0.8 million, $0.9 million, and $0.7 million, respectively.
Employee Stock Option  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
A summary of all ARX employee stock option activity during the years ended December 31, follows:
 
2019
 
2018
 
2017
Options Outstanding
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

Beginning of year
16,067

$
588.15

 
22,550

$
564.60

 
24,995

$
526.46

Add (deduct):
 
 
 
 
 
 
 
 
              Exercised1
(5,329
)
353.67

 
(6,483
)
506.26

 
(2,445
)
174.65

              Forfeited
(300
)
803.64

 
0

0

 
0

0

End of year
10,438

$
701.66

 
16,067

$
588.15

 
22,550

$
564.60

Exercisable, end of year
10,438

$
701.66

 
13,967

$
562.17

 
17,950

$
517.75

1 At the time of exercise, the value earned by the option holders was $5.9 million, $6.2 million, and $2.9 million in 2019, 2018, and 2017, respectively.
 
2019
 
2018
 
2017
Non-Vested Options Outstanding
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

 
Number of Shares

Weighted Average
Exercise Price

Beginning of year
2,100

$
760.93

 
4,600

$
747.45

 
8,000

$
712.74

Add (deduct):
 
 
 
 
 
 
 
 
Vested
(1,800
)
753.82

 
(2,500
)
736.12

 
(3,400
)
665.79

Forfeited
(300
)
803.64

 
0

0

 
0

0

End of year
0

$
0

 
2,100

$
760.93

 
4,600

$
747.45